| Literature DB >> 31414123 |
Mario Corbellino1, Nicolas Kieffer2, Mzia Kutateladze3, Nana Balarjishvili3, Lika Leshkasheli3, Lia Askilashvili3, George Tsertsvadze3, Sara Giordana Rimoldi4, Deia Nizharadze5, Naomi Hoyle5, Lia Nadareishvili5, Spinello Antinori1,6, Cristina Pagani4, Daniele Giuseppe Scorza4, Ai Ling Loredana Romanò7, Sandro Ardizzone6,8, Piergiorgio Danelli6,9, Maria Rita Gismondo4,6, Massimo Galli1,6, Patrice Nordmann2, Laurent Poirel2.
Abstract
In July 2017, a patient presented colonization with a multidrug-resistant, carbapenemase (KPC-3)-producing Klebsiella pneumoniae isolate. A custom-made, lytic bacteriophage preparation was administered to the patient in December 2017, with subsequent eradication of the microorganism and without adverse effects.Entities:
Keywords: antibiotic resistance; bacteriophage; multidrug-resistant Klebsiella pneumoniae; personalized phage therapy; selective decolonization
Mesh:
Substances:
Year: 2020 PMID: 31414123 DOI: 10.1093/cid/ciz782
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079